Regulation of substance P release mediated via prejunctional histamine H3 receptors. 1995

T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
Department of Pharmacology, Fukuoka Dental College, Japan.

The involvement of the histamine H3 receptor in the regulation of substance P release in neurogenic inflammation was studied by using rat hindpaw skin. R-(-)-alpha-Methylhistamine, a specific histamine H3 receptor agonist, significantly inhibited the increased vascular permeability induced by antidromic electrical stimulation of the sciatic nerve in a dose-dependent manner at doses of 0.5-3 mg/kg (i.v.), and thioperamide (2 mg/kg i.p.), a specific histamine H3 receptor antagonist, prevented the inhibitory effect of R-(-)-alpha-methylhistamine. The antidromic stimulation also caused a significant increase in immunoreactive substance P release in the subcutaneous (s.c.) perfusate in the rat hindpaw. R-(-)-alpha-Methylhistamine (0.25-2 mg/kg) dose dependently inhibited the increase in release of immunoreactive substance P, and thioperamide (2 mg/mg i.p.) antagonized it. Perfusion of histamine (10(-3) M) elicited a significant increase of immunoreactive substance P release in the perfusate, which was reduced by R-(-)-alpha-methylhistamine and the antagonism of thioperamide was also observed. Histamine (in the presence of histamine H1 and H2 receptor antagonists) had an inhibitory effect on the electrically evoked release of immunoreactive substance P. These results strongly support the hypothesis that histamine regulates substance P release via prejunctional histamine H3 receptors that are located on peripheral endings of sensory nerves.

UI MeSH Term Description Entries
D008297 Male Males
D008761 Methylhistamines Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors.
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D009475 Neurons, Afferent Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM. Afferent Neurons,Afferent Neuron,Neuron, Afferent
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010880 Piperidines A family of hexahydropyridines.
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine

Related Publications

T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
May 1998, Neuroscience research,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
August 1981, Naunyn-Schmiedeberg's archives of pharmacology,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
January 1993, Journal of neural transmission. General section,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
January 2011, The Journal of pharmacology and experimental therapeutics,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
October 1992, British journal of pharmacology,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
July 1988, Journal of neurochemistry,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
January 1994, Fundamental & clinical pharmacology,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
January 2022, Current topics in behavioral neurosciences,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
August 1993, Naunyn-Schmiedeberg's archives of pharmacology,
T Ohkubo, and M Shibata, and M Inoue, and H Kaya, and H Takahashi
December 1982, Die Pharmazie,
Copied contents to your clipboard!